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Virus-Specific CD8 T Cells in Peripheral Tissues
Are More Resistant to Apoptosis
Than Those in Lymphoid Organs
normally (Lohman et al., 1996; Razvi et al., 1995a; Reich
et al., 2000; Zimmermann et al., 1996b). This death might
be a consequence of growth factor removal (Deng and
Podack, 1993) or even may be a preprogrammed re-
sponse to occur after a resting T cell has undergone a
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specific number of cell divisions. The silencing of the
T cell response is not blocked in mice whose T cells
express a Bcl-2 transgene (Petschner et al., 1998; RazviSummary
et al., 1995a), but surviving activated T cells that become
memory cells express more Bcl-2 than the overall acti-CD8 T cells persist at high frequencies in peripheral
organs after resolution of an immune response, and vated T cell population (Grayson et al., 2000).
Memory CD8 T cells are heterogeneous in antigenictheir presence in the periphery is important for resis-
tance to secondary challenge. We show here that phenotype and phase of cell cycle (Mullbacher and
Flynn, 1996; Razvi et al., 1995b; Tough and Sprent,LCMV-specific T cells in peripheral tissue (peritoneal
cavity, lung, fat pads) reacted much less with the apo- 1994). It has been suggested that there may be at least
two kinds of memory CD8 T cells—“central” memoryptotic marker Annexin-V than those in spleen and
lymph nodes. This was not due to a TCR-based selec- cells that are resting cytolytically inactive cells that can
proliferate in response to antigen and rapidly replenishtion. In comparison to lymphoid tissue, T cells in the
periphery expressed lower levels of Fas and Fas ligand the effector cell pool, and “effector” memory cells that
are more terminally differentiated in regards to height-and were resistant to activation-induced cell death in
vitro. This may contribute to the survival of nondividing ened levels of cytolytic effector function and more lim-
ited cell division potential (Masopust et al., 2001; Rein-peripheral memory T cells, enabling them to efficiently
function without being driven into apoptosis. hardt et al., 2001; Sallusto et al., 1999). The effector
memory cells may be at increased frequency in periph-
eral tissue, where they would serve to engage a patho-Introduction
gen on secondary infection.
What has not been analyzed is whether the CD8 T cellVigorous CD8 T cell responses that occur during viral
infections usually come to a halt shortly after infectious apoptosis that terminates an immune response occurs
equally in all organs. Differential sensitivity to apoptosisvirus is cleared, and homeostasis is restored by dra-
matic reductions in their numbers in the spleen and at the termination of an immune response could lead to
a disproportionate skewing of memory T cells in somelymph nodes (Ahmed and Gray, 1996; Razvi et al.,
1995a). Many of these CD8 T cells undergo apoptosis organs but not others. Resistance to apoptosis could
allow for the survival of a long-lasting effector T cell(Razvi et al., 1995a), whereas a few are spared death
and enter the long-lasting memory pool (Ahmed and population that could productively respond to antigen
rechallenge without undergoing AICD. Here, we provideGray, 1996; Zinkernagel et al., 1996). Other T cells dis-
perse into peripheral organs, where they reside at rela- evidence in mice acutely infected with lymphocytic
choriomeningitis virus (LCMV) that antigen-specific CD8tively high frequencies as peripheral memory cells,
ready to respond to secondary stimulation on re- T cells from the lymphoid organs and the peripheral
tissue differ dramatically in apoptotic markers and inencounter with the pathogen (Chen et al., 2001; Hogan
et al., 2001; Mackay et al., 1992; Marshall et al., 2001; their susceptibility to FasL-mediated AICD.
Masopust et al., 2001; Reinhardt et al., 2001).
Highly activated CD8 T cells are prone to undergo Results
apoptosis, in part because they express low levels of
antiapoptotic proteins of the Bcl-2 family (Broome et Reactivity of MHC Dimer-Identified Antigen-Specific
al., 1995). They also may express Fas and Fas ligand CD8 T Cells with Annexin-V
and TNF and TNF receptor, and, if stimulated strongly Among the many assays for the detection of apoptotic
through their T cell receptor (TCR), they undergo apo- cells, few have been useful for quantifying dying cells
ptosis by the mechanism of activation-induced cell in vivo because macrophages phagocytize apoptotic
death (AICD) (Lenardo et al., 1999; Russell et al., 1991). cells via scavenging receptors for phosphatidyl serine,
Triggering through the TCR can, in fact, rapidly upregu- which is expressed very early on the surface of apoptotic
late Fas and FasL expression in T cells that have been cells (van Engeland et al., 1998). Expression of phospha-
previously activated (Lenardo et al., 1999; Nagata and tidyl serine, which can be detected by Annexin-V, occurs
Golstein, 1995). AICD may not, however, be the mecha- prior to events associated with DNA degradation, com-
nism for the silencing of the T cell response at the termi- plete caspase pathway activation, and alterations in
nation of infection. Antigen is no longer present to trigger membrane permeability. We therefore used Annexin-V
the TCR, and CD8 T cells from mice deficient in AICD to identify putatively preapoptotic CD8 T cells in the
cofactors such as Fas, FasL, and TNF undergo silencing lymphoid and peripheral organs of mice infected with
LCMV, and for these experiments we identified the anti-
gen-specific T cells by costaining them with LCMV pep-*Correspondence: raymond.welsh@umassmed.edu
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Figure 1. Low Frequency of Annexin-V Binding LCMV-Specific T Cells in Nonlymphoid Organs
Leukocytes were isolated from day 0 (A) or day 9 LCMV acutely infected C57BL/6 mice and stained with NP396 (B)-, GP33 (C)-, or NP205
(D)-specific IgG1-MHC dimers, anti-CD8, and Annexin-V. Data were gated on lymphocyte (A) or CD8 cells (B–D) with 300–700 forward scatter
(FSC) units. The organs were spleen, axillary lymph node (AXL), mesenteric lymph node (MST), mediastinal lymph node (MDL), liver, peritoneal
cavity (PEC), fat pad, and lung. The y axis represents Annexin-V staining, and the x axis represents CD8 (A) or dimer (B–D) staining. The
numbers recorded in the right upper quadrants represent the percent of CD8 (A)- or LCMV-specific CD8 T cells (B–D) staining with Annexin-V.
The numbers under each panel represent the mean fluorescent intensity (MFI) of Annexin-V staining of CD8 (A)- or LCMV-specific CD8 T cells
(B–D). All the day 9 data were derived from one single mouse, but they were representative of six individual experiments with two to three
mice in each experiment.
tide-charged MHC-dimers. Staining was done in the Annexin-V binding cells were seen in T cells of some
specificities (e.g., NP396 and NP205) than of other speci-cold to prevent ligand-induced AICD of the T cells.
Figure 1 shows Annexin-V binding of NP396-, GP33-, ficities (e.g., GP33), but T cells of each specificity dem-
onstrated similar organ-dependent differences. Table 1and NP205-specific CD8 T cells in various organs of
mice 9 days after intraperitoneal LCMV infection. The also shows data compiled from mice 2 and 4 months
after resolution of the LCMV infection to determineresults show, for each LCMV epitope, a much higher
reactivity with Annexin-V in the spleen and lymph nodes whether the tissue-dependent differences were main-
tained in the memory state. Surprisingly, there was stillthan in several peripheral organs, including the perito-
neal cavity, lung, and fat pad. These differences could substantially more Annexin-V binding in antigen-specific
T cells in the spleen and lymph nodes than in the perito-be shown by scoring the frequency of Annexin-V “”
cells, depicted in the upper right hand quadrants, and neal cavity, fat pads, or lungs. Thus, the phenotype is
long-lasting. The data presented in Figure 1 and Tableby the less arbitrary mean fluorescent intensities (MFI)
within the antigen-specific T cell populations (Figure 1). 1 were based on “viable” lymphocyte gates, spanning
300–700 forward scatter (FSC) units, but it should beThe liver, previously described to be a graveyard for
apoptotic CD8 T cells in other systems (Huang et al., noted that the dramatic tissue-related differences in
Annexin-V binding T cells were still apparent even when1994; Liu et al., 2001), had intermediate levels of
Annexin-V staining. Annexin-V staining in every tissue “wide-open” gates were examined (e.g., for the NP396
cells in Figure 1B gated at FSC 200–800, spleen 59%;was higher in LCMV-specific cells than in the overall
CD8 T cell population (Table 1), and, except in the liver, PEC  7.7%).
The silencing of the LCMV-induced T cell responseAnnexin-V staining of CD8 T cells prior to infection was
quite low. Table 1 shows additional data for days pre- occurs independently of Fas and FasL expression (Loh-
man et al., 1996; Razvi et al., 1995a; Zimmermann etceding or following the day 9 peak in the T cell response,
and the same pattern was seen for each time point. Of al., 1996b). Consistent with this observation, antigen-
specific T cells from LCMV-infected lpr and gld micenote, and for unknown reasons, higher proportions of
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Table 1. Percentage of Annexin-V-Positive Antigen-Specific CD8 T Cells in Lymphoid and Nonlymphoid Organs during Acute LCMV Infection
Annexin-V (%)
Spleen AXL MST MDL Liver PEC Fat Pad Lung
Day 0 CD8 4.7  1.4 2.2  0.7 2.6  0.5 2.2  0.9 32  6.7 2.6  1.2 5.2  0.9 8.9  0.1
Day 7 p.i. CD8 38  4.7 11  2.9 17  2.3 27  3.4 34  12 7.2  6.1 9.2  0.9 22  5.1
NP396 70  3.0 34  16 53  2.0 51  6.9 48  3.3 7.6  3.5 11  3.2 24  7.3
GP33 51  14 25  14 43  3.2 37  9.6 39  7.6 5.4  0.8 9.1  1.9 19  6.7
NP205 62  23 38  7.6 54  1.0 45  2.5 44  1.2 6.7  1.9 1.4  4.6 18  4.4
Day 9 p.i. CD8 26  4.1 12  3.0 19  5.4 26  9.6 30  5.8 6.3  4.2 7.2  2.2 10  3.4
NP396 44  9.3 36  11 49  11 62  12 32  5.4 6.7  5.4 7.1  1.5 8.9  1.9
GP33 38  5.4 26  10 35  15 37  18 21  0.4 2.7  0.9 4.6  1.6 7.0  1.9
NP205 47  11 34  12 45  13 62  14 36  2.9 5.3  2.1 8.2  4.3 8.8  4.5
Day 12 p.i. CD8 34  6.8 6.7  3.1 15  5.2 17  1.2 18  7.6 3.4  1.4 2.9  0.3 7.4  2.3
NP396 57  9.4 34  12 57  4.2 62  8.5 28  7.7 4.2  1.9 5.1  1.3 7.6  0.4
GP33 50  8.1 22  0.5 39  0.1 42  0.8 23  8.7 3.1  0.1 3.0  1.0 7.3  0.5
NP205 51  9.6 33  3.1 53  5.2 53  0.2 34  1.2 4.5  0.5 5.8  0.4 10  2.3
2–4a months p.i. CD8 8.4  0.9 4.3  1.2 5.5  0.5 6.2  1.6 16  1.4 6.4  3.6 4.8  2.5 3.8  1.8
NP396 47  5.6 37  6.7 47  11 31  15 25  4.0 15  5.8 13  4.8 5.4  0.6
GP33 28  2.2 14  9.0 30  22 11  2.1 23  1.7 11  5.5 14  4.7 5.5  2.4
The % of Annexin-V total CD8 cells on LCMV-epitope-specific CD8 T cells was determined at different days postinfection, as described
in the legend to Figure 1. (N  3 to six individuals)
a Data average from two mice 2 months p.i. and two mice 4 months p.i.
had similar Annexin-V reactivity as those in wild-type of these cells, which then undergo apoptosis (Petschner
et al., 1998; Zimmermann et al., 1996a) and react withmice (e.g., % Annexin-V staining of NP396 cells at day
9 p.i. in the spleen, AXL, PEC, and fat pad: gld-42, 46, Annexin-V (Figure 3). The GP33-transgenic T cells
stained with Annexin-V at relatively high levels in the2.4, 5.3; lpr-40, 57, 3.9, 6.9).
spleen and axillary lymph node (similar data from mes-
enteric lymph node are not shown), but hardly at all inNo Evidence for TCR-Based Affinity Maturation
the peritoneal cavity, fat pads, and lung. This clearlyDuring infections, there is an antigen-driven selection
established that this organ-dependent variance infor T cells based on their affinity or avidity with MHC-
Annexin-V staining was not TCR based, and it providedbearing peptide ligands (Chen et al., 2000). We therefore
a mechanism to examine a TCR homogeneous popula-questioned whether the lack of Annexin-V reactivity of
tion of T cells in different organs.T cells in peripheral organs was a consequence of a
TCR-based selection of T cells. CDR3 spectratype anal-
yses were performed on antigen-specific T cells that Bona Fide Apoptosis versus Delayed Clearance
We were surprised at the high frequencies of Annexin-Vhad been stained with NP396 peptide-charged MHC-
tetramers, sorted by FACS, and analyzed for the exis- binding cells in the lymphoid organs and questioned
if Annexin-V was detecting a stage in cell activationtence of dominant V8.1 clones in windows defined
by J1.1, 1.2, 1.3, 1.4, 1.5, and 2.1. Figure 2 shows unrelated to apoptosis. However, immunofluorescent
staining of known T cell activation markers includingresults from three experiments. Similar spectratypes of
NP396-specific T cells purified from spleen, PEC, fat 1B11(CD43), CD44, CD69, CD122, and Ly6C showed as
high or higher expression of these antigens on peripheralpad, and lung (day 9 postinfection) are shown for 6 J
windows in Figure 2A. A total of five experiments showed T cells (data not shown). This high frequency of Annexin-V
T cells in lymphoid tissue might reflect a delayed clear-that the antigen-specific spectratypes were similar from
organ to organ within individual mice. In the two experi- ance of apoptotic cells in lymphoid tissue compared to
peripheral tissue. It should be noted, however, that thements shown in Figures 2B and 2C, dominant singular
J1.1 and 1.2 peaks of sorted NP396-specific cells from TUNEL assay, which measures cells in later stages of
apoptosis undergoing DNA fragmentation, detectedspleen, fat pad, and lung of individual mice were se-
quenced across the CDR3 region. Identical dominant very few (6%) antigen-specific T cells in the spleen
(gated as above), suggesting that the spleen clearancesequences were seen among the different organs, but
the sequences of the two mice differed from each other, pathway was functioning effectively.
The TUNEL assay is not useful for quantifying apopto-as would be predicted (Lin and Welsh, 1998). These
experiments argue against the concept of a TCR-based sis in lymphocytes immediately ex vivo but can be reliable
once cells are put into culture. We therefore questionedselection of T cells in the peripheral organs being re-
sponsible for the differences in Annexin-V staining. whether Annexin-V splenic T cells were committed to
undergo DNA fragmentation by FACS-sorting Annexin-To further establish that the organ-dependent differ-
ences in Annexin-V-reactive T cells were not functions V from Annexin-V splenocytes, putting them into cul-
ture for 5 hr at 37C and then staining them with theof T cell selection, studies were performed on LCMV
GP33-specific transgenic Thy 1.2 T cells that were in- TUNEL assay to monitor DNA fragmentation. Here, day
9 LCMV-infected Thy1.1 mice implanted with Thy1.2oculated into Thy 1.1 congenic mice and traced during
an LCMV infection. LCMV induces a dramatic expansion LCMV-specific transgenic T cells were used, and trans-
Immunity
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Figure 2. Similar V8.1 CDR3-Length Spectratypes of CD8NP396 Tetramer Cells from Different Organs of a LCMV Day 9 Infected Mouse
(A) Spectratypes of 6 Js from four organs of an individual mouse. Fluorescent intensity (y axis) was plotted against relative CDR3 size (x axis).
(B and C) Sequences of CDR3 regions of dominant J1.1 and 1.2 peaks from three organs of two individual mice.
Figure 3. Low Frequency of Annexin-V Bind-
ing LCMV-Specific Transgenic T Cells in Non-
lymphoid Organs
Thy1.2 LCMV-specific transgenic T cells
were adoptively transferred into Thy1.1 B6
mice. Nine days after LCMV infection, leuko-
cytes were stained with anti-Thy1.2, anti-
CD8, and Annexin-V. Data were gated on
CD8Thy1.2 transgenic cells as shown in (A)
for a spleen sample. The Annexin-V versus
CD8 stainings of donor cells from spleen (B),
AXL (C), PEC (D), fat pad (E), and lung (F)
are shown. The numbers in the right upper
quadrants represent the percent of trans-
genic T cells staining as Annexin-V. The
numbers under each panel represent the MFI
of Annexin-V staining of the transgenic
T cells. Data were from one single mouse and
were representative of five individual experi-
ments with two to three mice in each exper-
iment.
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but not from the Annexin-V population. This does not
prove that all of the Annexin-V cells would have frag-
mented their DNA in vivo, but it clearly shows that they
were in a preapoptotic state. Similarly, when unsorted
splenocytes, PEC, or lung leukocytes were cultured for
5 hr, much higher proportions of the splenocytes were
stained by TUNEL assay (Figure 4B). Hence, the organ-
dependent differences were revealed by a reliable indi-
cator of apoptosis shortly after placement in culture.
Organ-Dependent Differences in Susceptibility
to AICD
Spleen T cells of LCMV-infected mice become very sus-
ceptible to AICD stimulated by triggering the TCR with
anti-CD3 antibody (Razvi and Welsh, 1993). Leukocytes
from spleen, representing the lymphoid organs, and
peritoneal cavity, representing the peripheral organs,
were therefore placed into culture and stimulated with
anti-CD3 and IL-2. Thy1.1 mice reconstituted with
Thy1.2 GP33-specific transgenic T cells were used,
such that the percentage of Annexin-V and TUNEL stain-
ing and the number of antigen-specific transgenic
Thy1.2 T cells could be enumerated by FACS. Figure
5A shows the effect of anti-CD3 stimulation on a naive
transgenic T cell population. To simulate a normal con-
trol environment, spleen leukocytes from naive TCR-
transgenic Thy 1.2 mice were mixed 1:3 with spleen
leukocytes from uninfected control Thy1.1 mice, and
PEC from transgenic mice were mixed 1:3 with PEC
from control mice. A 40 hr treatment with anti-CD3
caused little change in number (No:) in either the naive
spleen or PEC populations compared to unstimulated
cells and did not induce Annexin-Vbright staining on either
population, indicating that apoptosis was not being in-
duced in the naive populations at this time point.
The effects of a 40 hr anti-CD3 treatment were quite
different in leukocyte populations taken from day 9
LCMV-infected mice (Figure 5B). Anti-CD3 treatment of
transgenic T cells from LCMV-infected spleens caused
a 80% reduction in their number in comparison to
unstimulated controls, and the great proportion (60%)
of the residual cells stained with Annexin-V, indicative
of high levels of AICD. In marked contrast, anti-CD3
induced a slight increase in the number of transgenic
T cells from the LCMV-infected peritoneal cavity, and
most of the residual cells (60%) were defined as
Figure 4. TUNEL Staining of Freshly Isolated T Cells after Short In Annexin-V. These results were supported by TUNEL
Vitro Incubation stains shown from the same experiment in Figure 5B.
(A) Splenocytes of Thy1.1 mice reconstituted with Thy1.2 LCMV Analyses of other lymph nodes gave results similar to
transgenic T cells were stained with Annexin-V 9 days after infection.
spleen, and analysis of T cells from fat pads and lungAnnexin-V and Annexin-V cells were sorted and cultured at 37C
gave results similar to the PEC (data not shown). Thisor 4C (without IL-2) as control for 5 hr and then analyzed with
experiment argues that virus-specific splenic CD8TUNEL assay. “Total spleen” was not stained with Annexin-V or
sorted. T cells devoid of the splenic architecture are much more
(B) Unsorted leukocytes from spleen, PEC, and lung from similar susceptible to AICD than are peritoneal T cells.
mice were cultured at 37C or 4C for 5 hr and stained with TUNEL. We next questioned whether the sensitivity to apopto-
Data were gated on CD8 cells. The numbers in the left upper and
sis was an intrinsic property of the T cell or whether theright upper quadrants represent the percentage of TUNEL staining
leukocyte environment controlled this process. There-of host CD8 T cells and of the transgenic T cells, respectively.
fore, PEC from LCMV-infected mice containing the
transgenic T cells were mixed with 9-fold excess spleno-
cytes from LCMV-infected mice not containing thegenic and host T cells were monitored on gated CD8
lymphocytes. Figure 4A shows that incubation at 37C transgenic T cells, and spleen cells from LCMV-infected
mice containing the transgenic T cells were mixed withresulted in very high TUNEL staining of both transgenic
and host T cells derived from the Annexin-V population 9-fold excess PEC from LCMV-infected mice not con-
Immunity
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Figure 5. Resistance of PEC but Not Spleen
T Cells to AICD and Influence of the Leuko-
cyte Environments
Data were gated on the Thy1.2 transgenic
T cells, as in Figure 3.
(A) Naive T cells. Spleen leukocytes or PEC
from the Thy1.2 TCR-transgenic uninfected
mice were mixed 1:3, respectively, with
spleen leukocytes or PEC from uninfected
Thy1.1 mice, to simulate a normal environ-
ment in which the transgenic T cells could be
traced after stimulation in vitro. They were
then cultured with or without anti-CD3, all in
the presence of IL-2 for 40 hr. The panels
show the Annexin-V versus anti-CD8 staining
of the transgenic T cells.
(B–D) In vivo-activated T cells. Nine days after
LCMV infection, spleen leukocytes and PEC
from Thy1.1mice reconstituted with Thy1.2
transgenic T cells were stimulated with anti-
CD3 and IL-2 as in group (A). (B) The panels
on the left show results from splenocytes or
PEC cultured separately. The panels on the
right show experiments where splenocytes
from a day 9 LCMV-infected transgenic T cell-
containing mouse were mixed 1:9 with PEC
from a day 9 LCMV-infected Thy1.1 mouse
not reconstituted with transgenic T cells, or
else PEC from a transgenic-T cell-containing
mouse mixed 1:9 with splenocytes from a day
9 LCMV-infected mouse not containing trans-
genic T cells (C and D). LCMV-infected spleen
and PEC cells were incubated with anti-
CD3 and with IgG control or anti-FasL for 40
hr and stained with anti-CD8, anti-Thy1.2, and
Annexin-V (C) or, in a separate experiment,
TUNEL stain (D). The number on each panel
indicates the % of Annexin-V- or TUNEL-
staining cells. All incubations were set up at
106 cells per well, and cells from replica wells
were pooled for FACS analysis. Total viable
cells were counted by trypan blue stain; the
number under each panel represents the
number of transgenic T cells remaining per
well after 40 hr of stimulation. This was calcu-
lated by multiplying the total number of viable
cells times the percentage of transgenic cells.
taining the transgenic T cells (Figure 5B). Putting the transgenic T cells were also protected from apoptosis
by PEC depleted of T cells by anti-Thy1.1 and C	sensitive splenic T cells into the PEC environment re-
sulted in a substantial increase (5-fold) in their number (60%→14%).
AICD of LCMV-induced T cell populations dependsafter anti-CD3 treatment, and few of the cells stained
with Annexin-V, consistent with the concept that on Fas/FasL interactions (Lohman et al., 1996). Here,
either antibody to FasL or an isotype control was addedAnnexin-V reactivity is not simply a measure of T cell
activation. Conversely, putting PEC T cells into the into the 40 hr AICD assays. In three experiments, 10 
g/
ml anti-FasL caused an average of a 2.5  0.9-fold (p splenocyte environment caused a modest reduction in
their number, and a high frequency of them stained with 0.03) increase in numbers of the splenic transgenic
T cells and an average of 41%  10% reduction in theAnnexin-V after the anti-CD3 treatment. This pattern was
seen in three separate experiments, and the trend of % of Annexin-V splenocytes (p  0.02) and a 33% 
3.8% reduction of MFI (p  0.04) (one-tailed, paired Treduced apoptosis of spleen cells in the PEC environ-
ment (57%→27%) and increased susceptibility of PEC test). A representative experiment is shown in Figure
5C. A similar experiment using the TUNEL stain in FigureT cells in the splenic environment (19%→32%) was also
seen with the TUNEL stain (Figure 5B). Thus, the leuko- 5D shows a dramatic loss in TUNEL spleen cells in the
presence of anti-FasL; here, very few TUNEL cells werecyte environment influenced the sensitivity of the T cells
to AICD. Additional experiments showed that spleen in the PEC. These results confirm that the AICD observed
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here, in contrast to the apoptosis associated with the peptide, or anti-CD3 in order to stimulate the TCR. The
differences in Fas expression between freshly isolatedsilencing of the T cell response in vivo, was predomi-
nately mediated by Fas/FasL interactions. spleen and PEC T cells disappeared after 5 hr in culture,
possibly due to death of the Fas-bearing cells, and these
expression levels were virtually identical to those of na-Factors Contributing to the Tissue-Dependent
ive T cells (data not shown). However, the responses ofDifferences in Apoptosis
the residual T cells from the spleen and lymph node toWe questioned whether there were tissue-dependent
stimulation were markedly different from those from thedifferences in expression of genes known to regulate
peripheral tissue. Stimulation of splenocytes with GP33T cell apoptosis and first focused on the apoptotic regu-
or anti-CD3 but not with the control NP396 peptidelators Bcl-2 and cFLIP, thought to be upregulated in
caused about a 2- to 2.5-fold enhancement in MFI formemory T cell populations (Grayson et al., 2000; Inaba
Fas in spleen transgenic T cells (Figure 6B) and axialet al., 1999). We tested for Bcl-2 protein expression by
lymph nodes (data not shown). In the PEC (Figure 6B)immunofluorescence of transgenic T cells from different
and lung (data not shown) transgenic T cells, this stimu-tissues and found no significant differences; the MFI in
lation also caused an upregulation of Fas, but it wasthe transgenic T cells isolated from spleen, axial lymph
considerably less than that observed with the spleno-node, PEC, and lung were 26, 29, 29, and 25, respec-
cytes (Figure 6B).tively. The MFI of an IgG isotype control in each organ
In vitro stimulation with GP33 or anti-CD3 but notwas 6. Because cFLIP is transcriptionally controlled,
NP396 similarly caused about a 2-fold (100%) increasewe assessed its mRNA expression as part of a DNA
in MFI for FasL in the transgenic T cells from the spleenmicroarray experiment (Inaba et al., 1999). Spleen and
(Figure 6B) and lymph node (data not shown). IncreasesPEC transgenic T cells were sorted to at least 98% purity
in MFI for FasL in transgenic T cells in the PEC (Figurein three experiments, two at day 7 and one at day 9 p.i.
6B) and lung (data not shown) were much less (aboutThe gene expression patterns of spleen and PEC T cells
30%; this low-level increase was seen in each of threewere compared using Affymetrix DNA microarray
experiments). Interestingly, when spleen transgenic T cellsMG_U74Av2. The experiments revealed no significant
were placed into an environment of excess PEC, as de-differences in FLIP mRNA expression (signals at D7, D7
scribed in Figure 5, their expression of FasL decreasedand D9: spleen-328, 430, 380; PEC-271, 367, 357). These
greatly (e.g., FasL MFI in spleen  45, in PEC  14).experiments suggest that the reason for PEC T cell resis-
Addition of soluble FasL enhanced the Annexin-V re-tance to apoptosis is not because they are more mem-
activity of peritoneal transgenic T cells in 5 hr assaysory-like than spleen T cells. Of the 141 apoptosis-related
in the presence or absence of TCR stimulation. Thisgenes analyzed, 82 genes had a normalized signal inten-
indicates that some PEC T cells could be driven intosity flagged as “present” in either the spleen or PEC in
apoptosis on receipt of a strong proapoptotic stimulusat least one of three experiments. Of these 82 genes,
(Figure 6C), but even in the presence of FasL, the PEConly granzyme A had a greater than 2.2-fold different
were more resistant than spleen T cells. This result isnormalized signal intensity between spleen and PEC.
likely influenced greatly by the reduced expression ofGranzyme A expression in the spleen T cells was 6, 3.6,
Fas on the PEC T cells (Figure 6B), an interpretationand 13 times greater than in the PEC T cells (signals at
supported by costaining cells with Annexin-V and anti-D7, D7 and D9: spleen-12123, 7274, 9421; PEC-2034,
body to Fas, showing that cells from either the spleen2016, 720).
or PEC could undergo apoptosis if they expressed Fas.The genechip analyses did not detect sufficiently
For example, after exposure to anti-CD3 and 100 ngstrong signals of Fas mRNA to analyze, but differences
FasL, day 9 spleen CD8 T cells defined as Annexin-Vin cell surface Fas protein expression were shown by
(200 MFI) had a Fas MFI of 233, and Annexin-V spleenimmunofluorescence staining of LCMV-specific trans-
T cells had an Fas MFI of 87; PEC CD8 T cells definedgenic T cells isolated from the various tissues. Figure
as Annexin-V had a Fas MFI of 187, and Annexin-V6A shows immunofluorescent staining with mAb to Fas
had a Fas MFI of 97. Figure 6D shows the trend of highand FasL in freshly isolated leukocyte populations. The
Fas and high Annexin-V costaining in a similar experi-results indicated that antigen-specific T cells from the
ment using 50 ng/ml FasL.spleen and lymph node had nearly double the MFI for
Fas as those from the PEC and lung. This observation
was seen in three independent experiments. The freshly Discussion
isolated spleen and lymph node T cells also had slightly
higher staining for FasL, a result of questionable signifi- High frequencies of antigen-specific T cells accumulate
in peripheral organs during infections and remain therecance.
Expression of FasL on activated T cells tends to be as memory cells for prolonged time periods (Chen et
al., 2001; Hogan et al., 2001; Masopust et al., 2001;transient, and optimal expression requires a recent stim-
ulation through the TCR (Nagata and Golstein, 1995). Reinhardt et al., 2001). It has been suggested that T cells
leave the spleen and lymph nodes and enter the periph-We questioned whether in vitro stimulation with antigen
would reveal significant tissue-dependent differences in ery during the later stages of a T cell response and that
the total loss in T cell number during the silencing phaseFas or FasL expression. Therefore, leukocytes isolated
from day 9 LCMV-infected GP33-specific transgenic of the response is proportionally greater in the lymphoid
than in the peripheral tissues (Marshall et al., 2001; Ma-T cell-containing spleen or PEC were cultivated for 5 hr
in the presence of control NP396 peptide, specific GP33 sopust et al., 2001; Reinhardt et al., 2001). Memory
Immunity
638
Figure 6. Fas and FasL Expression of LCMV-Specific Transgenic T Cells 8 Days after Infection and sFasL-Induced Apoptosis
(A) Fas and FasL staining of freshly isolated LCMV-specific transgenic T cells. (B) Fas and FasL staining of restimulated LCMV-specific
transgenic T cells. Lymphocytes were isolated from LCMV-infected mice as described in Figure 3 and stained with mAb to CD8, Thy1.2, and
Fas or FasL immediately (A) or were stimulated with peptide or anti-CD3 mAb for 5 hr and stained.
(B) Data were gated on CD8 Thy1.2 donor transgenic T cells. The numbers in the upper right quadrants of each panel represent the MFI
of Fas or FasL staining of corresponding organ. The line is drawn directly above the unstimulated sample in order to highlight the increases
seen after stimulation. Similar results were observed in mice from 10 or 12 days after infection.
(C) % of Annexin-V staining of day 9 LCMV-infected spleen (open diamond) and PEC (filled square) transgenic T cells incubated with sFasL
for 5 hr.
(D) Annexin-V and Fas staining of CD8 T cells from anti-CD3-stimulated spleen and PEC with 50 ng/ml sFasL for 16 hr.
T cells in the spleen and lymph nodes undergo homeo- have reduced cell division and slowly decline in number
over a period of several months (Harris et al., 2002).static division to maintain their frequencies (Harris et
al., 2002; Razvi et al., 1995b; Tough and Sprent, 1994; Peripheral T cells, though not rapidly dividing, are at
relatively high activation states, as defined by cytolyticZimmermann et al., 1996a), but T cells in the periphery
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activity and activation antigen expression, and this may Van Parijs et al., 1999). Leukocytes from peripheral or-
enable them to be uniquely suited for protective immu- gans have high percentages of activated macrophages,
nity (Chen et al., 2001; Hogan et al., 2001; Masopust et which produce high levels of TGF, shown to inhibit
al., 2001; Reinhardt et al., 2001). Under conditions where FasL expression (Assoian et al., 1987; Genestier et al.,
memory T cell frequencies in the spleen and lymph node 1999). In three experiments adding either antibody to
are maintained, protective T cell immunity against a pe- TGF or an isotype control antibody into 40 hr AICD
ripheral viral challenge can be lost if memory T cells in assays, 10 
g/ml of anti-TGF caused an average of
the periphery have declined in number (Hogan et al., 2001). 10% 5% increase in the MFI of Annexin-V splenocytes
Our studies reveal additional dramatic differences be- (p  0.04) and a 37%  11% increase in the MFI in PEC
tween lymphoid and peripheral CD8 T cells and suggest (p  0.03). TGF may, then, be one of perhaps several
mechanisms that explain the high frequencies in the factors protecting peripheral T cells from AICD.
periphery and why they may be uniquely suited for effec- The spontaneous apoptosis during the silencing of
tively engaging pathogens. First of all, a surprisingly the T cell response occurs by a different mechanism
high proportion of antigen-specific T cells in the spleen than the TCR-induced AICD. Silencing of the immune
and lymph nodes display a preapoptotic phenotype, as response occurs normally in mice bearing mutations in
shown by Annexin-V binding, but those T cells residing Fas or FasL (Lohman et al., 1996; Razvi et al., 1995a;
in the periphery do not. We cannot be sure that all of Zimmermann et al., 1996b), and we show here that
these preapoptotic cells complete the apoptotic pro- T cells from LCMV-infected lpr and gld mice have
cess in vivo, but they rapidly fragment their DNA when Annexin-V staining patterns similar to those in normal
placed in culture (Figure 4A). Second, whereas the acti- infected mice. The heightened expression of Fas may
vated T cells in the spleen undergo AICD and fail to herald other genes contributing to a proapoptotic intra-
proliferate on TCR ligation in vitro (Razvi and Welsh, cellular environment. Of interest, however, is that few
1993), those in the periphery have increased survival changes in apoptotic gene expression were seen from
and resistance to AICD (Figure 5). This resistance to freshly isolated T cells, with the exception of granzyme
AICD by peripheral T cells is associated with their poor A, which was considerably higher in spleen T cells. Gran-
expression of the proapoptotic molecule FasL after sig- zyme A is a protease thought to be involved mostly in
naling through their TCR and to their low expression of T cell-dependent cytotoxicity rather than T cell apopto-
its signaling receptor, Fas (Figure 6). Given that T cell sis (Jenne and Tschopp, 1988). Future work should de-
apoptosis may be influenced by FasL-expressing T cells termine what role, if any, it plays in the silencing of the
in their environment (Nagata and Golstein, 1995), it is T cell response or in augmenting the sensitivity of these
not surprising that susceptibility to AICD was conferred cells to AICD.
on peripheral T cells placed into an environment of ex- The tissue-dependent differences in preapoptotic
cess FasL-bearing cells from lymphoid organs (Figure cells were not confined to a unique time period, but
5). Conversely, when spleen transgenic T cells were put occurred at 7, 9, and 12 days after acute LCMV infection
into a peripheral leukocyte environment, they resisted and 2 and 4 months later in the memory state. We were
apoptosis and downregulated FasL expression. surprised at the relatively high frequencies of Annexin-
Immunofluorescence data also showed that lymphoid V-reactive memory T cells 2–4 months postinfection, as
organ T cells expressed higher levels of Fas and FasL these frequencies are higher than that which would be
than did peripheral tissue T cells, consistent with their predicted of the number of cells in cycle, as shown by
enhanced sensitivity to AICD. No other tested activation BrdU studies (Zimmermann et al., 1996a). It is interesting
markers (1B11(CD43), CD44, CD69, CD122, Ly6C) were to note, however, that memory cells in lymphoid organs
expressed more highly on lymphoid than peripheral are constantly undergoing homeostatic division without
T cells. Of note is that we found no differences in freshly an increase in number, indicating that an apoptotic event
isolated cells in expression of Bcl-2, an antiapoptotic
must offset each cell division.
protein reported to be expressed higher in memory than
A differential propensity to apoptosis may play a role
in activated LCMV-specific CD8 T cells (Grayson et al.,
in the overall maintenance of antigen-specific T cells in2000). Our earlier studies had found no significant role
lymphoid and nonlymphoid tissue. If effective memoryfor Bcl-2 in the overall silencing of the CD8 T cell response
to peripheral challenge does wane with time and corre-in the spleen or in the sensitivity of LCMV-induced
sponds with the decline in frequency in peripheral mem-splenic T cells to AICD (Razvi et al., 1995a).
ory cells (Hogan et al., 2001), then it would serve theAn important question is why T cells in the peripheral
host to preserve the functional integrity of such cells,tissues have different expression of Fas and FasL and
to maintain their viability, and to have them responddifferent apoptotic properties than those in the spleen
productively rather than apoptotically to antigen stimu-and lymph nodes. Antigen-presenting cells delivering
lation. We show here that reduced sensitivity of periph-signals to the T cells may differ in these organs, as CD8
eral T cells to apoptosis on exposure to ligand providesT cells in peripheral tissue may be stimulated mostly
a mechanism for maintaining their numbers and theirby parenchymal cells, macrophages, and/or immature
functional integrity.dendritic cells, whereas those in the lymphoid organs
may be stimulated primarily by mature dendritic cells.
Experimental ProceduresExpression of Fas and FasL on lymphocytes can be
altered by integrins and cytokines, such as 12 integ- Mice
rins, IL-2, IL-6, INF, and TGF1, leading to a modified C57BL/6J and B6.PLThy1a/C (Thy1.1) male mice were purchased
susceptibility to AICD (Aoudjit and Vuori, 2000; Ayroldi from the Jackson Laboratory (Bar Harbor, ME). B6.SJL (Ly5.1) male
mice were from Taconic labs (Germantown, NY). Mice were usedet al., 1998; Genestier et al., 1999; Kaser et al., 1999;
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at 6–12 weeks of age. P-14 TCR transgenic mice that express a p.i., leukocytes were isolated from different organs, and donor cells
were identified by flow cytometry using anti-Thy1.2 mAb (Phar-transgenic TCR specific to the LCMV-encoded class I MHC-pre-
sented peptide GP33-41 (Pircher et al., 1989) were purchased from mingen). The proportion of transgenic T cells varied in the leukocyte
population from different tissues, with the ranges at day 9 postinfec-Jackson Laboratories and were backcrossed onto RAG/ C57BL/6
mice (Thy 1.2 Ly5.2) by Dr. Joseph Maciaszek at UMMS. tion being 3%–5% for spleen, 1%–2% for LN, 30%–40% for PEC,
10%–20% for lung, and 30%–40% for fat pad.
Virus
Induction of AICD In Vitro and TUNEL StainingMice were inoculated intraperitoneally (i.p.) with 0.1 ml of 4  104
Leukocytes were stimulated with mAb to CD3 (145-2C11; Phar-plaque-forming units (PFU) of the Armstrong strain of LCMV diluted
mingen) in vitro in 48-well tissue culture plates coated with 2 
gin PBS (Razvi and Welsh, 1993).
purified anti-CD3 mAb overnight at 4C. Other wells were sham-
treated. To each well were then added freshly isolated 106 leuko-Preparation of Leukocytes
cytes along with 0.02 
g human recombinant interleukin-2 (IL-2)Mice were anesthetized by an i.p. injection of Nembutal (Abbott
(Pharmingen) in 1 ml MLC-RPMI medium (Lohman and Welsh, 1998).laboratories, IL). Leukocytes from the PEC were collected by lavag-
These cells were then cultured for 40 hr at 37C and analyzed bying with 10 ml cold RPMI 1640 medium (GIBCO, Gaithersburg, MD).
flow cytometry for antigen specificity, cell number, and apoptoticThe lung vascular bed was flushed with 10 ml chilled Hank’s bal-
properties. Anti-FasL (clone MFL3) or an IgG isotype control (10anced salt solution (HBSS, GIBCO) introduced via cannulation of

g/ml) (eBioscience, San Diego, CA) was added to spleen or PECthe right ventricle of the heart. Blood from liver was flushed by
leukocytes. Cells were incubated with anti-CD3 for 40 hr and stainedinjecting 5 ml of RPMI through the portal vein. Single-cell suspen-
with antibodies. Sensitivity to FasL-induced apoptosis was moni-sions from spleens and lymph nodes were made by grinding the
tored by adding soluble FasL and a crosslinking enhancer Ig to cellsorgans between glass microscope slides. Fat pads and lungs were
for 5 hr at 37C, according to manufacturer’s instructions (Alexis,minced and incubated for 45–60 min at 37C in 0.5 mg/ml type II
San Diego, CA). TUNEL staining was applied with a terminal trans-collagenase (Sigma-Aldrich, St. Louis, MO) and 100 U/ml type I
ferase kit (Roche, Indianapolis, IN) according to the manufacturer’sDNase (Sigma-Aldrich). Lung leukocytes were collected by a
instructions.Lympholyte-M (Cedarlane Labs, Hornby, Canada) density gradient
(Chen et al., 2001). Leukocytes from the liver were isolated by crush-
Immunofluorescent Staining with Antibodies to Fas, FasL,ing the liver in a tissue grinder, incubating with enzyme solution, and
and Bcl-2collecting the leukocyte layer from a metrizamide (Sigma-Aldrich)
Leukocytes were stained with mAb to PerCP-CD8, APC-Thy1.2, anddensity gradient (Daniels et al., 2001). Contaminating erythrocytes
Biotin-Fas (clone Jo2) or FasL (clone Kay-10) (Pharmingen) for 30were removed from the leukocyte preparations by treatment with
min at 4C. In some cases, cells were stained intracytoplasmically0.84% NH4Cl.
with a PE-Bcl-2 mAb (clone 3F11) or its IgG isotype control (clone
A19-3) with Cytofix/Cytoperm Kit (Pharmingen), according to theH2Db- and H2Kb-IgG1 MHC Dimer- and Annexin-V-Staining
manufacturer’s instructions. In some cases, leukocytes from LCMV-of Leukocytes
infected mice were first stimulated with 5 
M synthetic GP33-41 orDb-IgG1 dimers (Greten et al., 1998; Selin et al., 1999) were used
NP396-404 peptide or 2
g anti-CD3 mAb for 5 hr at 37C before stainingwith the LCMV immunodominant peptides NP396-404 (FQPQNGQFI)
with mAbs to Fas and FasL.(Gairin et al., 1995) and GP33-41 (AVYNFATC) (Whitton et al., 1988). Kb-
IgG1 dimers (Pharmingen) were used with the subdominant NP205-212
Gene Microarray Analysis(YTVKYPNL) peptide (van der Most et al., 1998). The dimers were
Affymetrix, Inc. (Santa Clara, CA) gene array analyses were doneincubated with 0.15 
g 2-microglobulin and 800-fold molar excess
according to the manufacturer’s procedures manual. Total RNA waspeptide for 7 days at 4C. For staining, 1 
g of peptide-charged
isolated from cells using RNeasy Mini Kit (QIAGEN). cDNA was syn-dimer was incubated with 106 leukocytes for 1.5 hr at 4C. The cells
thesized using SuperScript DS cDNA synthesis kit (Invitrogen, Lifewere then incubated with biotinylated anti-mouse IgG1 and PerCP-
Technologies) with T7-(dT)24 primer (Genset Corp). The biotin-anti-CD8, and then with PE-streptavidin (Pharmingen), all done at
labeled cRNA was transcribed and labeled using RNA transcript4C. The cells were then washed and incubated in Annexin-V binding
labeling kit (Enzo Diagnostics, Inc, Farmingdale, NY). Labeled cRNAbuffer with FITC-Annexin-V (Pharmingen) at a 1:20 dilution for 15
was fragmented and hybridized to MG-U74Av2 microarray chips andmin at room temperature. The cells were washed, resuspended in
expression analysis was done with Microarray Suite 5.0. “Apoptosis-Annexin-V binding buffer, and analyzed by flow cytometry immedi-
related genes” were analyzed by GeneSpring 5.0 (Silicon Genetics,ately.
Redwood City, CA).
H2Db MHC Tetramer Staining and Sorting
Acknowledgments106 leukocytes were incubated with PE-NP396-specific H2Db tetra-
mer (Murali-Krishna et al., 1998; Mylin et al., 2000) and FITC-anti-
We thank S.S. Tevethia, K.A. Kraemer, D.M. Pardoll, and J.P.CD8 (Pharmingen) for 1 hr at 4C. After staining, the cells were sorted
Schneck for assistance with MHC-tetramer and MHC-IgG dimerby flow cytometry using a FACSTAR sorter.
protocols, and Phyllis Spatrick, Dr. Herald Hills, and Keith Daniels
for technical assistance. This work was supported by National Insti-CDR3 Length Spectratyping Analysis
tutes of Health research grants AR35506 and AI17672 (to R.M.W.),CDR3 length “spectratype” analysis was done as described (Lin
AI-46578 (to L.K.S.), Center Grant DK32520, and Training grantsand Welsh, 1998; Pannetier et al., 1993). In brief, RNA samples were
AI07349 (to M.A.B.) and AI07272 (to S.E.S.). The contents of thisamplified with primers for C and for V8.1, using a GeneAmp RNA
publication are solely the responsibility of the authors and do notkit (Perkin-Elmer Corp., Branchburg, NJ). The PCR products were
represent the official view of the National Institutes of Health.subjected to five cycles of runoff reaction with 6 fluorophore-labeled
J primers (J 1.1, 1.2, 1.3, 1.4, 1.5, and 2.1). The runoff products
Received: April 5, 2002were loaded onto a 4.75% acrylamide sequencing gel and analyzed
Revised: January 31, 2003on an automated DNA sequencer using GeneScan software (Applied
Accepted: February 26, 2003Biosystems, Foster City, CA).
Published: May 13, 2003
Adoptive Transfer Studies
ReferencesTwo  106 leukocytes from spleen and lymph nodes of P14 LCMV-
specific TCR transgenic RAG/ Thy1.2 mice were injected intrave-
Ahmed, R., and Gray, D. (1996). Immunological memory and protec-nously via the retro-orbital sinus into B6.PL Thy1a/C (Thy1.1) (or
tive immunity: understanding their relation. Science 272, 54–60.B6.SJL (Ly5.1) for one D 7 Genechip experiment) mice. The mice
were inoculated with LCMV 1 to 3 days thereafter. At 8 to 12 days Aoudjit, F., and Vuori, K. (2000). Engagement of the alpha2beta1
Resistance of Peripheral T Cells to Apoptosis
641
integrin inhibits Fas ligand expression and activation-induced cell sis–immune regulation in a dynamic and unpredictable antigenic
environment. Annu. Rev. Immunol. 17, 221–253.death in T cells in a focal adhesion kinase-dependent manner. Blood
95, 2044–2051. Lin, M.Y., and Welsh, R.M. (1998). Stability and diversity of T cell
receptor repertoire usage during lymphocytic choriomeningitis virusAssoian, R.K., Fleurdelys, B.E., Stevenson, H.C., Miller, P.J., Madtes,
infection of mice. J. Exp. Med. 188, 1993–2005.D.K., Raines, E.W., Ross, R., and Sporn, M.B. (1987). Expression
and secretion of type beta transforming growth factor by activated Liu, Z.X., Govindarajan, S., Okamoto, S., and Dennert, G. (2001). Fas-
human macrophages. Proc. Natl. Acad. Sci. USA 84, 6020–6024. mediated apoptosis causes elimination of virus-specific cytotoxic
T cells in the virus-infected liver. J. Immunol. 166, 3035–3041.Ayroldi, E., Zollo, O., Cannarile, L., D’Adimo, F., Grohmann, U., Del-
fino, D.V., and Riccardi, C. (1998). Interleukin-6 (IL-6) prevents activa- Lohman, B.L., and Welsh, R.M. (1998). Apoptotic regulation of T cells
tion-induced cell death: IL-2-independent inhibition of Fas/fasL ex- and absence of immune deficiency in virus-infected gamma inter-
pression and cell death. Blood 92, 4212–4219. feron receptor knockout mice. J. Virol. 72, 7815–7821.
Broome, H.E., Dargan, C.M., Krajewski, S., and Reed, J.C. (1995). Lohman, B.L., Razvi, E.S., and Welsh, R.M. (1996). T-lymphocyte
Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 downregulation after acute viral infection is not dependent on CD95
withdrawal. J. Immunol. 155, 2311–2317. (Fas) receptor-ligand interactions. J. Virol. 70, 8199–8203.
Mackay, C.R., Marston, W.L., Dudler, L., Spertini, O., Tedder, T.F.,Chen, H.D., Fraire, A.E., Joris, I., Brehm, M.A., Welsh, R.M., and
and Hein, W.R. (1992). Tissue-specific migration pathways by phe-Selin, L.K. (2001). Memory CD8 T cells in heterologous antiviral
notypically distinct subpopulations of memory T cells. Eur. J. Immu-immunity and immunopathology in the lung. Nat. Immunol. 2, 1067–
nol. 22, 887–895.1076.
Marshall, D.R., Turner, S.J., Belz, G.T., Wingo, S., Andreansky, S.,Chen, W., Anton, L.C., Bennink, J.R., and Yewdell, J.W. (2000). Dis-
Sangster, M.Y., Riberdy, J.M., Liu, T., Tan, M., and Doherty, P.C.secting the multifactorial causes of immunodominance in class
(2001). Measuring the diaspora for virus-specific CD8 T cells. Proc.I-restricted T cell responses to viruses. Immunity 12, 83–93.
Natl. Acad. Sci. USA 98, 6313–6318.Daniels, K.A., Devora, G., Lai, W.C., O’Donnell, C.L., Bennett, M.,
Masopust, D., Vezys, V., Marzo, A.L., and Lefrancois, L. (2001). Pref-and Welsh, R.M. (2001). Murine cytomegalovirus is regulated by a
erential localization of effector memory cells in nonlymphoid tissue.discrete subset of natural killer cells reactive with monoclonal anti-
Science 291, 2413–2417.body to Ly49H. J. Exp. Med. 194, 29–44.
Mullbacher, A., and Flynn, K. (1996). Aspects of cytotoxic T cellDeng, G., and Podack, E.R. (1993). Suppression of apoptosis in a
memory. Immunol. Rev. 150, 113–127.cytotoxic T-cell line by interleukin 2-mediated gene transcription
and deregulated expression of the protooncogene bcl-2. Proc. Natl. Murali-Krishna, K., Altman, J.D., Suresh, M., Sourdive, D.J., Zajac,
Acad. Sci. USA 90, 2189–2193. A.J., Miller, J.D., Slansky, J., and Ahmed, R. (1998). Counting anti-
gen-specific CD8 T cells: a reevaluation of bystander activationGairin, J.E., Mazarguil, H., Hudrisier, D., and Oldstone, M.B. (1995).
during viral infection. Immunity 8, 177–187.Optimal lymphocytic choriomeningitis virus sequences restricted
Mylin, L.M., Schell, T.D., Roberts, D., Epler, M., Boesteanu, A., Col-by H-2Db major histocompatibility complex class I molecules and
lins, E.J., Frelinger, J.A., Joyce, S., and Tevethia, S.S. (2000). Quanti-presented to cytotoxic T lymphocytes. J. Virol. 69, 2297–2305.
tation of CD8() T-lymphocyte responses to multiple epitopes fromGenestier, L., Kasibhatla, S., Brunner, T., and Green, D.R. (1999).
simian virus 40 (SV40) large T antigen in C57BL/6 mice immunizedTransforming growth factor beta1 inhibits Fas ligand expression and
with SV40, SV40 T-antigen-transformed cells, or vaccinia virus re-subsequent activation-induced cell death in T cells via downregula-
combinants expressing full-length T antigen or epitope minigenes.tion of c-Myc. J. Exp. Med. 189, 231–239.
J. Virol. 74, 6922–6934.
Grayson, J.M., Zajac, A.J., Altman, J.D., and Ahmed, R. (2000). Cut-
Nagata, S., and Golstein, P. (1995). The Fas death factor. Scienceting edge: increased expression of Bcl-2 in antigen-specific memory
267, 1449–1456.CD8 T cells. J. Immunol. 164, 3950–3954.
Pannetier, C., Cochet, M., Darche, S., Casrouge, A., Zoller, M., and
Greten, T.F., Slansky, J.E., Kubota, R., Soldan, S.S., Jaffee, E.M.,
Kourilsky, P. (1993). The sizes of the CDR3 hypervariable regions
Leist, T.P., Pardoll, D.M., Jacobson, S., and Schneck, J.P. (1998).
of the murine T-cell receptor beta chains vary as a function of the
Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-
recombined germ-line segments. Proc. Natl. Acad. Sci. USA 90,
specific CD8() T cells are activated in peripheral blood and accu-
4319–4323.
mulate in cerebrospinal fluid from HAM/TSP patients. Proc. Natl.
Petschner, F., Zimmerman, C., Strasser, A., Grillot, D., Nunez, G.,Acad. Sci. USA 95, 7568–7573.
and Pircher, H. (1998). Constitutive expression of Bcl-xL or Bcl-2
Harris, N.L., Watt, V., Ronchese, F., and Le Gros, G. (2002). Differen- prevents peptide antigen-induced T cell deletion but does not influ-
tial T cell function and fate in lymph node and nonlymphoid tissues. ence T cell homeostasis after a viral infection. Eur. J. Immunol. 28,
J. Exp. Med. 195, 317–326. 560–569.
Hogan, R.J., Usherwood, E.J., Zhong, W., Roberts, A.A., Dutton, Pircher, H., Burki, K., Lang, R., Hengartner, H., and Zinkernagel,
R.W., Harmsen, A.G., and Woodland, D.L. (2001). Activated antigen- R.M. (1989). Tolerance induction in double specific T-cell receptor
specific CD8 T cells persist in the lungs following recovery from transgenic mice varies with antigen. Nature 342, 559–561.
respiratory virus infections. J. Immunol. 166, 1813–1822.
Razvi, E.S., and Welsh, R.M. (1993). Programmed cell death of T
Huang, L., Soldevila, G., Leeker, M., Flavell, R., and Crispe, I.N. lymphocytes during acute viral infection: a mechanism for virus-
(1994). The liver eliminates T cells undergoing antigen-triggered induced immune deficiency. J. Virol. 67, 5754–5765.
apoptosis in vivo. Immunity 1, 741–749.
Razvi, E.S., Jiang, Z., Woda, B.A., and Welsh, R.M. (1995a). Lympho-
Inaba, M., Kurasawa, K., Mamura, M., Kumano, K., Saito, Y., and cyte apoptosis during the silencing of the immune response to acute
Iwamoto, I. (1999). Primed T cells are more resistant to Fas-mediated viral infections in normal, lpr, and Bcl-2-transgenic mice. Am. J.
activation-induced cell death than naive T cells. J. Immunol. 163, Pathol. 147, 79–91.
1315–1320. Razvi, E.S., Welsh, R.M., and McFarland, H.I. (1995b). In vivo state
Jenne, D.E., and Tschopp, J. (1988). Granzymes, a family of serine of antiviral CTL precursors. Characterization of a cycling cell popula-
proteases released from granules of cytolytic T lymphocytes upon tion containing CTL precursors in immune mice. J. Immunol. 154,
T cell receptor stimulation. Immunol. Rev. 103, 53–71. 620–632.
Kaser, A., Nagata, S., and Tilg, H. (1999). Interferon alpha augments Reich, A., Korner, H., Sedgwick, J.D., and Pircher, H. (2000). Immune
activation-induced T cell death by upregulation of Fas (CD95/APO- down-regulation and peripheral deletion of CD8 T cells does not
1) and Fas ligand expression. Cytokine 11, 736–743. require TNF receptor-ligand interactions nor CD95 (Fas, APO-1).
Eur. J. Immunol. 30, 678–682.Lenardo, M., Chan, K.M., Hornung, F., McFarland, H., Siegel, R.,
Wang, J., and Zheng, L. (1999). Mature T lymphocyte apopto- Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T., and Jenkins, M.K.
Immunity
642
(2001). Visualizing the generation of memory CD4 T cells in the whole
body. Nature 410, 101–105.
Russell, J.H., White, C.L., Loh, D.Y., and Meleedy-Rey, P. (1991).
Receptor-stimulated death pathway is opened by antigen in mature
T cells. Proc. Natl. Acad. Sci. USA 88, 2151–2155.
Sallusto, F., Lenig, D., Forster, R., Lipp, M., and Lanzavecchia, A.
(1999). Two subsets of memory T lymphocytes with distinct homing
potentials and effector functions. Nature 401, 708–712.
Selin, L.K., Lin, M.Y., Kraemer, K.A., Pardoll, D.M., Schneck, J.P.,
Varga, S.M., Santolucito, P.A., Pinto, A.K., and Welsh, R.M. (1999).
Attrition of T cell memory: selective loss of LCMV epitope-specific
memory CD8 T cells following infections with heterologous viruses.
Immunity 11, 733–742.
Tough, D.F., and Sprent, J. (1994). Turnover of naive- and memory-
phenotype T cells. J. Exp. Med. 179, 1127–1135.
van der Most, R.G., Murali-Krishna, K., Whitton, J.L., Oseroff, C.,
Alexander, J., Southwood, S., Sidney, J., Chesnut, R.W., Sette, A.,
and Ahmed, R. (1998). Identification of Db- and Kb-restricted sub-
dominant cytotoxic T-cell responses in lymphocytic choriomeningi-
tis virus-infected mice. Virology 240, 158–167.
van Engeland, M., Nieland, L.J., Ramaekers, F.C., Schutte, B., and
Reutelingsperger, C.P. (1998). Annexin V-affinity assay: a review on
an apoptosis detection system based on phosphatidylserine expo-
sure. Cytometry 31, 1–9.
Van Parijs, L., Refaeli, Y., Lord, J.D., Nelson, B.H., Abbas, A.K., and
Baltimore, D. (1999). Uncoupling IL-2 signals that regulate T cell
proliferation, survival, and Fas-mediated activation-induced cell
death. Immunity 11, 281–288.
Whitton, J.L., Gebhard, J.R., Lewicki, H., Tishon, A., and Oldstone,
M.B. (1988). Molecular definition of a major cytotoxic T-lymphocyte
epitope in the glycoprotein of lymphocytic choriomeningitis virus.
J. Virol. 62, 687–695.
Zimmermann, C., Brduscha-Riem, K., Blaser, C., Zinkernagel, R.M.,
and Pircher, H. (1996a). Visualization, characterization, and turnover
of CD8 memory T cells in virus-infected hosts. J. Exp. Med. 183,
1367–1375.
Zimmermann, C., Rawiel, M., Blaser, C., Kaufmann, M., and Pircher,
H. (1996b). Homeostatic regulation of CD8 T cells after antigen
challenge in the absence of Fas (CD95). Eur. J. Immunol. 26, 2903–
2910.
Zinkernagel, R.M., Bachmann, M.F., Kundig, T.M., Oehen, S., Pir-
chet, H., and Hengartner, H. (1996). On immunological memory.
Annu. Rev. Immunol. 14, 333–367.
